Analysts weigh in on Moderna's big drop following cancer vaccine results

Moderna fell after leaked phase 3 cancer vaccine data sparked debate on melanoma benefit, approval odds, and uptake risks. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real